Form 4: Veracyte Director Muna Bhanji Sells 1,539 Shares Under 10b5-1 Plan
SEC Form 4
Director Muna Bhanji of Veracyte, Inc. executed a sale of 1,539 common stock shares at $21 per share on May 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 28, 2024, Muna Bhanji, a director of Veracyte, Inc., sold 1,539 shares of common stock.
- The sale was executed at a price of $21 per share.
- The transaction was conducted under a pre-existing Rule 10b5-1 trading plan adopted on February 27, 2024.
- Following the transaction, Muna Bhanji directly owns 26,975 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged plan. It doesn't indicate any positive or negative outlook for the company.
Industry Context
Sales by insiders are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by a director could have a minor negative impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| February 27, 2024 | Date the reporting person adopted the Rule 10b5-1 plan |
| May 28, 2024 | Date of the transaction (stock sale) |
| May 30, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.